Embryonic stem cells or induced Pluripotent stem cells? A DNA integrity perspective

Current Gene Therapy

Volumn 13, Issue 2, 2013, Pages 93-98

  Bai, Qiang ^a,b,c   Desprat, Romain ^a   Klein, Bernard ^a,b,c   Lemaître, Jean Marc ^a,d   de Vos, John ^a,b,c,e,f  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^e HÔPITAL SAINT ELOI   (France)

^f LIRMM   (France)

Author keywords

Cell reprogramming; DNA damage; Genetic abnormalities; Genome integrity; Induced pluripotent stem cells; Pluripotency

Indexed keywords

DOXYCYCLINE; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P16; PROTEIN P53; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL CULTURE; DNA DAMAGE; DNA MODIFICATION; EMBRYONIC STEM CELL; EPIGENETICS; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC DAMAGE; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; KARYOTYPING; MICROARRAY ANALYSIS; MUTATION; NONHUMAN; ONCOGENE C MYC; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DNA; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENOMIC INSTABILITY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE;

EID: 84876729698     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/1566523211313020003     Document Type: Article

References (62)

1. Ramirez JM, Bai Q, Dijon-Grinand M, Assou S, Gerbal-Chaloin S, Hamamah S, De Vos J. World J Stem Cells 2010; 2(2): 24-33.
2. Landry DW, Zucker HA. Embryonic death and the creation of human embryonic stem cells. J Clin Invest 2004; 114(9): 1184-1186.
3. Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 2012; 10(6): 678-684.
4. Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 2010; 120(1): 51-59.
5. Gourraud P-A, Gilson L, Girard M, Peschanski M. The role of human leukocyte antigen matching in the development of multiethnic haplobank of inducedpluripotent stem cell lines. Stem Cells 2012; 30(2): 180-186.
6. Lapasset L, Milhavet O, Prieur A, Besnard E, Babled A, et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev 2011; 25(21): 2248-2253.
7. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 2011; 13(5): 497-505.
8. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-676.
9. Hacein-Bey-Abina S, Kalle Von C, Schmidt M, McCormack MP, Wulffraat N, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302(5644): 415-419.
10. Okita K, Ichisaka T & Yamanaka S. Generation of germlinecompetent induced pluripotent stem cells. Nature 2007; 448(7151): 313-317.
11. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131(5): 861-872.
12. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324(5928): 797-801.
13. Mayshar Y, Ben-David U, Lavon N, Biancotti J-C, Yakir B, Clark AT, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7(4): 521-531.
14. Taapken SM, Nisler BS, Newton MA, Sampsell-Barron TL, Leonhard KA, McIntire EM, et al. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol 2011; 29(4): 313-314.
15. Chen Q, Shi X, Rudolph C, Yu Y, Zhang D, Zhao X, et al. Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines. Chromosome Res 2011; 19(7): 857-868.
16. Ben-David U, Benvenisty N. High Prevalence of Evolutionarilyconserved and Species-Specific Genomic Aberrations in Mouse Pluripotent Stem Cells. Stem Cells 2012; 30(4): 612-622.
17. Martins-Taylor K, Xu R-H (2010) Determinants of pluripotency: from avian, rodents, to primates. J Cell Biochem 2010; 109(1): 16-25.
18. Pasi CE, Dereli-Öz A, Negrini S, Friedli M, Fragola G, et al. Genomic instability in induced stem cells. Cell Death Differ 2011; 18(5): 745-753.
19. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R. Dynamic changes in the copy number of pluripotency and cell prolife ration genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011; 8(1): 106-118.
20. Hussein SMI, Batada NN, Vuoristo S, Ching RW, Autio R, Närvä E, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471(7336): 58-62.
21. Ji J, Ng SH, Sharma V, Neculai D, Hussein SMI, Sam M, et al. Elevated Coding Mutation Rate During the Reprogramming of Human Somatic Cells into Induced Pluripotent Stem Cells. Stem Cells 2012; 30(3): 435-440.
22. Gore A, Li Z, Fung H-L, Young JE, Agarwal S, Antosiewicz-Bourget J, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471(7336): 63-67.
23. Blasco MA, Serrano M, Fernandez-Capetillo O. Genomic instability in iPS: time for a break. EMBO J 2011; 30(6): 991-993.
24. Pera MF. Stem cells: The dark side of induced pluripotency. Nature 2011; 471(7336): 46-47.
25. Krizhanovsky V, Lowe SW. Stem cells: The promises and perils of p53. Nature 2009; 460(7259): 1085-1086.
26. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460(7259): 1132-1135.
27. Marión RM, Strati K, Li H, Murga M, Blanco R, Ortega S, et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009; 460(7259): 1149-1153.
28. Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009; 460(7259): 1136-1139.
29. Quinlan AR, Boland MJ, Leibowitz ML, Shumilina S, Pehrson SM, Baldwin KK, et al. Genome Sequencing of Mouse Induced Pluripotent Stem Cells Reveals Retroelement Stability and Infrequent DNA Rearrangement during Reprogramming. Cell Stem Cell 2011; 9(4): 366-373.
30. Young MA, Larson DE, Sun C-W, George DR, Ding L, Miller CA, et al. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 2012; 10(5): 570-582.
31. Abyzov A, Mariani J, Palejev D, Zhang Y, Haney MS, Tomasini L, et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 2012; 492(7429): 438-442.
32. Cheng L, Hansen NF, Zhao L, Du Y, Zou C, Donovan FX, et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 2012; 10(3): 337-344.
33. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292(5819): 154-156.
34. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-1147.
35. Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004; 22(1): 53-54.
36. The International Stem Cell Initiative, Amps KJ, Andrews PW, Anyfantis G, Armstrong L, Avery S, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011; 29(12): 1132-1144.
37. Lefort N, Feyeux M, Bas C, Féraud O, Bennaceur-Griscelli A, Tachdjian G, et al. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 2008; 26(12): 1364-1366.
38. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011; 11(4): 268-277.
39. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005; 37(10): 1099-1103.
40. Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 2010; 28(4): 371-377.
41. Mitalipova MM, Rao RR, Hoyer DM, et al. Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 2005; 23(1): 19-20.
42. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322(5903): 949-953.
43. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced Pluripotent Stem Cells Generated Without Viral Integration. Science 2008; 322(5903): 945-949.
44. Mali P, Ye Z, Hommond H, Yu X, Lin J, Chen G, et al. Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts. Stem Cells 2008; 26(8): 1998-2005.
45. Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A 2011; 108(34): 14234-14239.
46. Woltjen K, Michael I, Mohseni P, et al. piggy Bac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458(7239): 766-770.
47. Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136(5): 964-977.
48. Kim D, Kim C-H, Moon J-I, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4(6): 472-476.
49. Warren L, Manos PD, Ahfeldt T, et al. Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA. Cell Stem Cell 2010; 7(5): 618-630.
50. Lee J, Sayed N, Hunter A, et al. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 2012; 151(3): 547-558.
51. Singhal N, Graumann J, Wu G, et al. Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming. Cell 2010; 141(6): 943-955.
52. Subramanyam D, Lamouille S, Judson RL, et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011; 29(5): 443-448.
53. Jullien J, Pasque V, Halley-Stott RP, Mayamoto K, Gurdon B. Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process? Nat Rev Mol Cell Biol 2011; 12(7): 453-459.
54. Schwartz SD, Hubschman J-P, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012; 379(9817): 713-720.
55. Prockop DJ, Keating A. Re-Learning the Lessons of Genomic Stability of Human Cells During Expansion in Culture: Implications for Clinical Research. Stem Cells 2012; 30(6): 1051-1052.
56. Hayflick L, Perkins F, Stevenson RE. Human Diploid Cell Strains. Science 1964; 143(3609): 976.
57. Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 2011; 9(2): 97-102.
58. Eisenstein M. The Battle for sequencing supremacy. Nature Biotechnology 2012; 30: 1023-1026.
59. Kirkwood TBL (2005) Understanding the odd science of aging. Cell 2005; 120(4): 437-447.
60. Piotrowski A, Bruder CEG, Andersson R, et al. Somatic mosaicism for copy number variation in differentiated human tissues. Hum Mutat 2008; 29(9): 1118-1124.
61. Youssoufian H, Pyeritz RE. Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet 2002; 3(10): 748-758.
62. Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39(Database issue): D945-D950.